Page History
Overview
The Clinical Drug "containing precisely" (CD-precise) concept is an abstract representation of the precise active ingredient, basis of strength substance (BoSS), strength, and manufactured dose form of a drug product. It implies that the drug product must contain only the precise active ingredient(s) specified in the FSN.
Modeling for concepts representing continuous dose forms
CD-precise concepts are modeled using the proximal primitive modeling pattern. CD-precise concepts representing continuous dose form (e.g., solutions, suspensions, creams, ointments, patches) are modeled using concentration strength attributes; presentation strength attributes are not allowed for these concepts in the International Release.
...
- Product containing precisely zidovudine 10 milligram/1 milliliter conventional release oral solution (clinical drug)
- Product containing precisely amikacin (as amikacin sulfate) 250 milligram/1 milliliter conventional release solution for injection (clinical drug)
- Product containing precisely clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug)
- Product containing precisely mupirocin (as mupirocin calcium) 20 milligram/1 gram conventional release nasal ointment (clinical drug)
- Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug)
The following exceptions have been identified.
- Concepts with product strength that is "not equal to"
- These concepts will be modeled as primitive, with attributes added as described in the following sections, except that strength numerator attributes will not be added.
- These concepts will have the appropriate Medicinal Product Form-only (MPF-only) concept as an inferred parent.
For solids and semi-solids, a concentration strength will be mass/mass (w/w) – usually mg/g.*
For liquids, a concentration strength will be mass/volume (w/v) – usually mg/mL.
For clinical drugs that are different to the above, submitters need to give *
*Requests for new concepts that conflict with the above require a clear justification for the variance.
Modeling
Stated parent concept | 763158003 |Medicinal product (product)| | ||||
---|---|---|---|---|---|
Semantic tag | (clinical drug) | ||||
Definition status | 900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)| Exceptions:
| ||||
Attribute: Has manufactured dose form | Range: 736542009 |Pharmaceutical dose form (dose form)|
Cardinality: 1..1 The attribute value should represent the manufactured dose formPowder and granules for oral suspension, solution, etc., may be modeled using concentration strength and the administrable dose form (e.g. 1145409004 |Product containing precisely amoxicillin 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug)|) | ||||
Attribute: Count of base of active ingredient (attribute) | Concrete Type: Integer Range: >#0.. Cardinality: 1..1 | ||||
Relationship group | One relationship group containing one instance of each of the following attributes is required for each precise active ingredient. | ||||
| Range: <105590001 |Substance (substance) excluding concepts representing structural groupers, dispositions, or combined substances Cardinality: 1..1 per relationship group
| ||||
| Range: <105590001 |Substance (substance) excluding concepts representing structural groupers, dispositions, or combined substances Cardinality: 1..1 per relationship group | ||||
| Concrete Type: Decimal Range: >#0.. Cardinality: 1..1 per relationship group Expression of product strength in metric units is preferred. To avoid semantically equivalent concepts, product strength for metric units are normalized as follows:
To avoid semantically equivalent concepts, product strength for units are normalized as follows:
The following units are not allowed unless specifically noted as an exception:
Repeating decimals are rounded to three decimal places (with 5 and above rounded up and 4 and below rounded down). | ||||
| Range: <767524001 |Unit of measure (qualifier value)| Cardinality: 1..1 per relationship group | ||||
| Concrete Type: Decimal Range: >#0.. Cardinality: 1..1 per relationship group For this pattern, the attribute value must be 1. Note: the denominator strength value is required for concepts in the International Release even though the value = 1, because including denominators for only some concepts negatively affects the classification results. | ||||
| Range: <767524001 |Unit of measure (qualifier value)| Cardinality: 1..1 per relationship group For Clinical drug concepts with:
|
Naming
FSN | Use one of the following patterns for the FSN. Align naming and case sensitivity with the FSN for the concepts that are selected as the attribute values, excluding the semantic tag. For multiple ingredient drug products, the BoSS must be in alphabetical order and separated by the word “and”. Where Precise active ingredient = BoSS:
For example,
Where Precise active ingredient <> is not = BoSS:
For example,
| |
---|---|---|
Preferred Term | Use one of the following patterns for the PT. Align naming and case sensitivity with the PT for the concepts that are selected as the attribute values. For multiple ingredient drug products, the BoSS must be in alphabetical order and separated by the word “and”. Where Single ingredient with BoSS = Precise active ingredient:
For example,
Where Single ingredient with BoSS <> is not = Precise active ingredient:
For example,
Exception:
| |
Synonyms | Synonyms matching the FSN are not required.Synonyms converting metric units to percent or parts per millions may be included for medical gas concepts (e.g. Helium 79% and oxygen 21% gas for inhalation, Helium 790,000 ppm and oxygen 210,000 ppm gas for inhalation). |
Exemplars
The following illustrates the stated view for 781834001 |Product containing precisely digoxin 250 microgram/1 milliliter conventional release solution for injection (clinical drug)|:
...